Position in BIIB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,778,315
+$585,139 QoQ
Shares Held
12,859
+7.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#308
of 1,031 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. BIIB ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
This page
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in BIIB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,778,315 | 12,859 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,193,176 | 11,963 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,073,690 | 11,783 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,628,430 | 11,625 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,552,920 | 12,365 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,826,129 | 13,345 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $864,150 | 5,651 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $495,455 | 2,556 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $602,963 | 2,601 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $573,360 | 2,659 | Shares | Sole | 2024-04-15 | |
| 2023-09-30 | $688,015 | 2,677 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $814,671 | 2,860 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $848,547 | 3,052 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $846,821 | 3,058 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $815,418 | 3,054 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $653,627 | 3,205 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $690,768 | 3,280 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $840,439 | 3,503 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $952,827 | 3,367 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,142,691 | 3,300 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $945,275 | 3,379 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||